ArticleJournal of patient-reported outcomes2026
Validation of the fear of cancer recurrence inventory-short form in long-term colorectal cancer survivors.
Article in Journal of patient-reported outcomes, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe Fear of Cancer Recurrence Inventory-Short Form (FCRI-SF) is commonly used to categorize the severity of fear of cancer recurrence (FCR) defined as fear, worry, or concern about cancer returning or progressing. Evaluating the FCRI-SF factor structure and the clinical cut-off score in specific cancer populations and stages of survivorship is essential to determine its generalizability as a screening tool for clinical FCR. This study aimed to (1) examine the factor structure of the FCRI-SF, and (2) evaluate the clinical cut-off score in long-term colorectal cancer survivors without recurrence. METHODOLOGY: Data were drawn from a national cohort study on late effects after colorectal cancer and a randomized trial evaluating an online FCR intervention. Exploratory and confirmatory factor analyses were conducted to examine the latent structure of the FCRI-SF. The optimal theoretical cut-off was assessed using weighted logistic regression to estimate sensitivity and specificity.
resultsA total of 5,515 survivors completed the FCRI-SF, and 334 underwent clinical FCR assessment. Factor analyses indicated a one-factor solution, though model fit indices were suboptimal. Item 5 showed poor psychometric performance, and item 9 had a bimodal response pattern. The optimal theoretical cut-off score for identifying clinical FCR was 22.
conclusionsThe FCRI-SF is a suitable tool for assessing FCR in long-term colorectal cancer survivors, but minor revisions to item 5 and item 9 may improve its psychometric properties.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.